Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference

    NEXT STORY
    AXIM® Biotechnologies Successfully Completes Point-of-Care Clinical Trials on its Rapid COVID-19 Neutralizing Antibody Test
    PREV STORY
    The global sepsis diagnostics market is projected to grow at a CAGR of 8.06% during the forecast period, 2021-2028
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Protein Therapeutics Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2012–2022

    LAS VEGAS, Nov. 20, 2017 (GLOBE NEWSWIRE) -- The Protein Therapeutics Market was worth ...

    author_avatar
    NASDAQ Market News

    Data on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on January 24th, 2018

    SAN DIEGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of ...

    author_avatar
    NASDAQ Market News

    Aptevo Therapeutics and MorphoSys End Joint Development and Commercialization Agreement for MOR209/ES414

    Aptevo Regains Worldwide Rights to Novel Bispecific Prostate Cancer Immunotherapeutic MOR209/ES414 Preliminary Phase I Data ...

    author_avatar
    NASDAQ Market News